Literature DB >> 12761607

Varying and "atypical" indications for atypical antipsychotics.

Corrado Barbui, Michele Tansella, Silvio Garattini.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12761607     DOI： 10.1007/s00213-003-1495-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  5 in total

1.  Adjusting Europe's drug regulation to public health needs.

Authors:  S Garattini; V Bertele
Journal:  Lancet       Date:  2001-07-07       Impact factor: 79.321

2.  Regulatory issues in Europe.

Authors:  C Barbui; G Guaiana; S Garattini
Journal:  J Clin Psychopharmacol       Date:  2001-12       Impact factor: 3.153

Review 3.  Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.

Authors:  J Geddes; N Freemantle; P Harrison; P Bebbington
Journal:  BMJ       Date:  2000-12-02

Review 4.  The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.

Authors:  R W Kerwin
Journal:  Br J Psychiatry       Date:  1994-02       Impact factor: 9.319

5.  Off-label use of antipsychotic drugs.

Authors:  E Weiss; M Hummer; D Koller; H Ulmer; W W Fleischhacker
Journal:  J Clin Psychopharmacol       Date:  2000-12       Impact factor: 3.153
  5 in total
  1 in total

1.  Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use.

Authors:  W Wolfgang Fleischhacker
Journal:  Psychopharmacology (Berl)       Date:  2003-05-22       Impact factor: 4.530
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.